CVE-2022-31885

CVE-2022-31885 is a critical-severity vulnerability in Marvalglobal Marval Msm with a CVSS 3.x base score of 9.8. Its EPSS exploit-prediction score of 31% places it in the 98th percentile, indicating an elevated likelihood of exploitation. The underlying weakness is classified as CWE-78.

Key facts

Description

Marval MSM v14.19.0.12476 is vulnerable to OS Command Injection due to the insecure handling of VBScripts.

Frequently asked questions

What is CVE-2022-31885?
Marval MSM v14.19.0.12476 is vulnerable to OS Command Injection due to the insecure handling of VBScripts.
How severe is CVE-2022-31885?
CVE-2022-31885 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2022-31885 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 31% (98th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-31885?
CVE-2022-31885 affects Marvalglobal Marval Msm. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2022-31885?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
When was CVE-2022-31885 published?
CVE-2022-31885 was published on 2022-06-28 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Marvalglobal Marval Msm

All CVEs affecting Marvalglobal Marval Msm →

Other CWE-78 (OS Command Injection) vulnerabilities

Browse all CWE-78 (OS Command Injection) vulnerabilities →